T. Rowe Price Associates

T. Rowe Price Associates’s scPharmaceuticals SCPH Stock Holding History

T. Rowe Price Associates’s Portfolio SCPH Stock Details SCPH Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$111K	Hold
2025 Q2	$75K	Buy
2025 Q1	$40K	Hold
2024 Q4	$54K	Buy
2018 Q2	–	Sell
2018 Q1	$3.79M	Buy
2017 Q4	$3.68M	Buy